Key facts
- This page summarizes Jeffrey A. Whitnell's Form 4 filing for ELITE PHARMACEUTICALS INC /NV/ (ELTP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Nov 2023, 19:05.
Jeffrey A. Whitnell - 22 Nov 2023 Form 4 Insider Report for ELITE PHARMACEUTICALS INC /NV/ (ELTP)
- Reporting relationship
- Director
- Issuer ticker
- ELTP
- Reported as of
- 22 Nov 2023
- Net transaction value
- +$19,989
- SEC form
- 4
- Accepted by SEC
- 27 Nov 2023, 19:05:38 UTC
- Prior SEC filing
- 29 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- Jeffrey Whitnell
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Jeffrey A. Whitnell filed Form 4 for ELITE PHARMACEUTICALS INC /NV/ (ELTP) on 27 Nov 2023.
Change
- Previous filing in this sequence was filed on 29 Aug 2022.
- Current net transaction value: +$19,989.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELTP
transaction
Common Stock
Award
- Transaction value
- $19,989
- Shares
- +547,657
- Change %
- +21%
- Price
- $0.0365
- Shares after
- 3,187,020
- Date
- 22 Nov 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.